Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Transplanted stem cells show promise for mending broken hearts

21.12.2005


Working with heart attack-stricken mice, a team of University of Wisconsin-Madison scientists has shown that embryonic stem cells may one day live up to their clinical promise.



In a paper to be published in the January 2006 issue of the Journal of Molecular and Cellular Cardiology, a team led by UW-Madison stem cell researcher and heart specialist Timothy J. Kamp reports that all-purpose embryonic stem cells, transplanted into mouse hearts damaged by experimentally induced heart attacks, shift gears and morph into functional forms of the major types of cells that compose the healthy heart.

The study’s results are important because they demonstrate that blank-slate embryonic stem cells can be introduced to damaged heart tissue, develop into heart muscle and into cells that form the heart’s blood vessels. If perfected, such therapy could provide a practical, less-invasive alternative to current therapies such as surgery, improve the quality of life for many patients and reduce the number of deaths attributed to heart disease, now estimated at about 700,000 deaths per year in the United States.


"Typically, when that heart muscle dies (as the result of heart attack), it is gone for good," says Kamp, a professor of medicine and physiology in the UW-Madison School of Medicine and Public Health.

In their experiments, when stem cells were introduced directly to tissue damaged by a heart attack, three critical types of cells formed: cardiomyocytes or heart muscle; vascular smooth muscle, the muscle that forms the bulk of the walls of blood vessels; and endothelial cells, the flat cells that line the interior surfaces of blood vessels in the heart and throughout the body’s circulatory system.

"There are multiple components," Kamp explains. "But (in these experiments) we see the three most important types of cells forming. It didn’t completely repair the heart, but it was encouraging."

Kamp emphasized that although results of the new study show promise for using stem cells to repair diseased and damaged tissue, clinical application remains a distant hope. Further studies in mice, primates and, ultimately, humans will be required to ensure efficacy and safety.

Composed mostly of muscle, the heart drives the circulatory system. When it is damaged by a heart attack, scar tissue forms and the heart struggles to do its job of pumping blood throughout the body. With enough tissue damage, congestive heart failure - often leading to death - can occur.

The new experiments were aimed at answering critical questions relative to repairing hearts that have been damaged by heart attacks: Would the cells be driven to repair the heart at the site of the injury, and what kinds of cells would they become?

The group’s finding showed that the cells did indeed migrate to the site of the injury and developed into the critical cell types. Perhaps most importantly, the transplanted cells improved the function of the damaged heart.

"The heart ballooned out less, and its ability to contract improved," Kamp says. "The transplanted cells seemed to respond to the area of active injury. There is something about the injury that favors engraftment and incorporation of those cells."

One intriguing result of the new study is that the implanted cells did not result in tumor formation, one of the primary safety concerns for stem cell therapy. Like cancer cells, embryonic stem cells have a capacity to reproduce indefinitely and scientists must perfect cell transplant methods that are safe before the therapy can be attempted in human patients.

Kamp says future studies will explore ways to refine the cell types used in treating heart disease to enhance safety. His group also plans to implant human cells in mice and non-human primates to further assess the viability of cell transplant therapy and issues of safety.

Timothy J. Kamp | EurekAlert!
Further information:
http://www.medicine.wisc.edu

More articles from Life Sciences:

nachricht Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel

nachricht Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>